AD-06-OB47_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, N-(4-aminobutyl)-5-chloronaphthalene-2-sulfonamide, CYP2C19 gene modulator targeting CYP2C19 (Novartis, 4299)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/4299
Similar Terms
Downloads & Tools

Genes

15 genes differentially expressed following the AD-06-OB47_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
SH3BP4 SH3-domain binding protein 4 1.25556
PPDPF pancreatic progenitor cell differentiation and proliferation factor 0.686724
LSM7 LSM7 homolog, U6 small nuclear RNA associated (S. cerevisiae) 0.631318
RBM3 RNA binding motif (RNP1, RRM) protein 3 0.592086
TRIM56 tripartite motif containing 56 0.533883
RPL31 ribosomal protein L31 0.513614
RPL18A ribosomal protein L18a 0.356615
MYL6 myosin, light chain 6, alkali, smooth muscle and non-muscle 0.24865
SNRPA small nuclear ribonucleoprotein polypeptide A 0.202705

decreased expression

Symbol Name Standardized Value
POLR2M polymerase (RNA) II (DNA directed) polypeptide M -0.292977
YY1AP1 YY1 associated protein 1 -0.266981
KCTD21 potassium channel tetramerization domain containing 21 -0.266981
TNRC6A trinucleotide repeat containing 6A -0.245144
CTR9 CTR9, Paf1/RNA polymerase II complex component -0.245144
PER3 period circadian clock 3 -0.217809